In the ‘Trajectory group characteristics’ subsection of the Results, there is an error in the fourth sentence. The correct sentence is: There was no significant relationship between increasing HAQ trajectory group and death during follow-up, but some higher trajectory groups had greater proportion of patients who started a biologic (see S1 Table).
There are several errors in S1 Table. Please view the correct S1 Table below.
Supporting information
† Hazard ratios calculated using Cox regression adjusted for age and gender.
‡ Group 2 chosen as reference category for biologic switching analysis, as group 1 only had one failure event, and this resulted in failures of the proportional hazards assumption. The proportional hazards assumption was met when group 2 was used as the reference category.
CI = confidence interval
bDMARD = biologic disease modifying anti-rheumatic drug.
(DOCX)
Reference
- 1.Pan Y, Norton S, Gwinnutt JM, Kearsley-Fleet L, Symmons DPM, Lunt M, et al. (2019) Not all moderate disease is the same–Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity. PLoS ONE 14(5): e0215999 10.1371/journal.pone.0215999 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
† Hazard ratios calculated using Cox regression adjusted for age and gender.
‡ Group 2 chosen as reference category for biologic switching analysis, as group 1 only had one failure event, and this resulted in failures of the proportional hazards assumption. The proportional hazards assumption was met when group 2 was used as the reference category.
CI = confidence interval
bDMARD = biologic disease modifying anti-rheumatic drug.
(DOCX)